ELDN
ELDN
NASDAQ · Biotechnology

Eledon Pharmaceuticals Inc

$3.94
+0.06 (+1.55%)
As of Jun 30, 10:27 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +206.9% upside
Low Target $9.42
Average Target $12.09
High Target $15.53
Current Price $3.94
Current
$3.94
Target
$12.09
$9.42 $12.09 avg $15.53
Scenario Analysis
Bear Case
$9.42
139.1%
Low target
Base Case
$12.09
+206.9%
Avg target
Bull Case
$15.53
+294.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.60
-14.3% from high
52-Week Low
$1.35
+191.9% from low
Target vs 52W High
$12.09
+162.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%